 FT. MYERS, FL ACCESSWIRE February 8, 2022 NeoGenomics, Inc. NASDAQ:NEO, a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced that members of senior management will be participating virtually in multiple upcoming institutional investor conferences. Management will participate in investor meetings and a fireside chat at the SVB Leerink Virtual 11th Annual Global Healthcare Conference on Thursday, February 17, 2022. 